반응 #1343518

ord-908d33e1485d49cca94786ff719a6b96

반응 방정식

Cc1cc2nc(NC(=O)c3ccc(C(C)(C)O)cc3)cc(Cl)n2n1
N-(7-chloro-2-methylpyrazolo[1,5-a]pyrimidin-5-yl)-4-(2-hydroxypropan-2-yl)benzamide
Cl.O=S1(=O)CCNCC1
S,S-dioxidothiomorpholine hydrochloride
CCN(C(C)C)C(C)C
N,N-diisopropylethylamine
Cc1cc2nc(NC(=O)c3ccc(C(C)(C)O)cc3)cc(N3CCS(=O)(=O)CC3)n2n1
titled compound
수율 37.0%
Cc1cc2nc(NC(=O)c3ccc(C(C)(C)O)cc3)cc(N3CCS(=O)(=O)CC3)n2n1
N-[7-(1,1-dioxidothiomorpholin-4-yl)-2-methylpyrazolo[1,5-a]pyrimidin-5-yl]-4-(1-hydroxy-1-methylethyl)benzamide
수율 37.0%

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    기타was then purified by preparatory HPLC (20-30% MeCN/H2O gradient+0.01% TFA)

실험 절차

A solution of N-(7-chloro-2-methylpyrazolo[1,5-a]pyrimidin-5-yl)-4-(2-hydroxypropan-2-yl)benzamide (2F, 110 mg, 0.319 mmol), S,S-dioxidothiomorpholine hydrochloride (164 mg, 0.957 mmol) and N,N-diisopropylethylamine (181 mg, 1.40 mmol) in DMF (1.28 mL) was stirred at 100° C. for 3 h. After cooling to room temperature, the mixture was diluted with methanol, and was then purified by preparatory HPLC (20-30% MeCN/H2O gradient+0.01% TFA). Lyophilization of the combined fractions gave the titled compound as a white solid (52.4 mg, 37%). 1H NMR (DMSO-d6) δ: 10.92 (s, 1H), 8.00 (d, J=8.8 Hz, 2H), 7.60 (d, J=8.6 Hz, 2H), 7.42 (s, 1H), 6.21 (s, 1H), 4.25 (br. s., 4H), 3.41 (br. s., 4H), 2.39 (s, 3H), 1.45 (s, 6H); ESI-MS: m/z 444.2 (M+H)+.

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US08461163B2uspto-grants-2013_06